Kvalme og opkastning induceret af medicinsk kræftbehandling

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Kvalme og opkastning induceret af medicinsk kræftbehandling. / Petersen, Peter Clausager; Ruhlmann, Christina; Herrstedt, Jørn.

I: Ugeskrift for Laeger, Bind 181, V02190115, 2019.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Petersen, PC, Ruhlmann, C & Herrstedt, J 2019, 'Kvalme og opkastning induceret af medicinsk kræftbehandling', Ugeskrift for Laeger, bind 181, V02190115. <https://ugeskriftet.dk/videnskab/kvalme-og-opkastning-induceret-af-medicinsk-kraeftbehandling>

APA

Petersen, P. C., Ruhlmann, C., & Herrstedt, J. (2019). Kvalme og opkastning induceret af medicinsk kræftbehandling. Ugeskrift for Laeger, 181, [V02190115]. https://ugeskriftet.dk/videnskab/kvalme-og-opkastning-induceret-af-medicinsk-kraeftbehandling

Vancouver

Petersen PC, Ruhlmann C, Herrstedt J. Kvalme og opkastning induceret af medicinsk kræftbehandling. Ugeskrift for Laeger. 2019;181. V02190115.

Author

Petersen, Peter Clausager ; Ruhlmann, Christina ; Herrstedt, Jørn. / Kvalme og opkastning induceret af medicinsk kræftbehandling. I: Ugeskrift for Laeger. 2019 ; Bind 181.

Bibtex

@article{f52b19669cf54fdc8bb8b47e3ddef031,
title = "Kvalme og opkastning induceret af medicinsk kr{\ae}ftbehandling",
abstract = "Nausea and vomiting are a persistent burden on cancer patients undergoing antineoplastic therapy, and adherence to guideline-specific prophylactic therapy is essential to minimise the risk. Nausea is more challenging to prevent than vomiting. This review summarises the choices of relevant drugs. Olanzapine is effective against nausea, but sedation can be a problem. There seems to be no major differences in effect or tolerability between different serotonin receptor antagonists and different neurokinin receptor antagonists. Consequently, the choice of drug should be based on price, risk of interactions and simple administration.",
keywords = "Antiemetics/therapeutic use, Antineoplastic Agents/adverse effects, Humans, Nausea/chemically induced, Neoplasms/drug therapy, Vomiting/chemically induced",
author = "Petersen, {Peter Clausager} and Christina Ruhlmann and J{\o}rn Herrstedt",
year = "2019",
language = "Dansk",
volume = "181",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",

}

RIS

TY - JOUR

T1 - Kvalme og opkastning induceret af medicinsk kræftbehandling

AU - Petersen, Peter Clausager

AU - Ruhlmann, Christina

AU - Herrstedt, Jørn

PY - 2019

Y1 - 2019

N2 - Nausea and vomiting are a persistent burden on cancer patients undergoing antineoplastic therapy, and adherence to guideline-specific prophylactic therapy is essential to minimise the risk. Nausea is more challenging to prevent than vomiting. This review summarises the choices of relevant drugs. Olanzapine is effective against nausea, but sedation can be a problem. There seems to be no major differences in effect or tolerability between different serotonin receptor antagonists and different neurokinin receptor antagonists. Consequently, the choice of drug should be based on price, risk of interactions and simple administration.

AB - Nausea and vomiting are a persistent burden on cancer patients undergoing antineoplastic therapy, and adherence to guideline-specific prophylactic therapy is essential to minimise the risk. Nausea is more challenging to prevent than vomiting. This review summarises the choices of relevant drugs. Olanzapine is effective against nausea, but sedation can be a problem. There seems to be no major differences in effect or tolerability between different serotonin receptor antagonists and different neurokinin receptor antagonists. Consequently, the choice of drug should be based on price, risk of interactions and simple administration.

KW - Antiemetics/therapeutic use

KW - Antineoplastic Agents/adverse effects

KW - Humans

KW - Nausea/chemically induced

KW - Neoplasms/drug therapy

KW - Vomiting/chemically induced

M3 - Tidsskriftartikel

C2 - 31267940

VL - 181

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

M1 - V02190115

ER -

ID: 240952287